LINC01366

Across TCGA pan-cancer cohorts, LINC01366 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC01366 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC01366 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01366 expression acts as an unfavorable survival marker, although some lineages such as ACC and OV show a favorable association.

STAD, KICH, and LIHC are the cancer types where LINC01366 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.321	0.548	<.001	83	view →
KICH	OS	Median	II,III,IV	0.574	1.000	.001	59	view →
LIHC	OS	Median	III,IV	0.379	0.765	<.001	42	view →
KIRP	OS	Median	III,IV	0.150	0.716	.011	36	view →
ACC	OS	Tertile	IV	0.968	0.392	.001	29	view →
LGG	OS	Median	All	0.743	0.892	.002	27	view →
DLBC	DFS	Median	III,IV	0.140	0.917	.010	21	view →
OV	OS	Quartile	All	0.903	0.795	.002	18	view →
UVM	DFS	Quartile	All	0.590	0.862	.026	17	view →
SKCM	DFS	Tertile	All	0.248	0.180	.010	17	view →
THYM	OS	Tertile	All	1.000	0.715	.006	17	view →
CHOL	OS	Quartile	II,III,IV	0.961	0.101	.010	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LINC01366–STAD (OS)

Open the STAD breakdown →